Determined Canadians embrace flexibility to maximize summer getaways with 68 per cent still looking to book
Skyscanner's Smarter Summer Report helps travellers get the most out of 2025 'Maximizer Summer' with expert tips and insights:
TORONTO, May 15, 2025 /CNW/ - According to new research from global travel app Skyscanner, a new trend is emerging: the Maximizer Summer. In 2025, Canadian travellers don't just want summer - they want more of it - and they're planning smarter to make it happen. As part of its new Smarter Summer Report, Skyscanner's survey found that 88 per cent of Canadians believe it's important to maximize their summer vacation this year.
'It's not just about where you go but how you plan.' Laura Lindsay, Skyscanner's Travel Expert. 'Canadians are taking a more intentional approach this year, looking to extend every aspect of their time off, from stretching their budget and travel time to staying flexible and exploring more destinations.'
Top 10 Most Affordable Destinations for Canadians:
Cheapest Week to Travel: Week of August 25
Cheapest Day to Fly: Friday
FOR THE FULL RELEASE CLICK HERE
Visit Skyscanner.ca for more information about the leading travel app.
ABOUT SKYSCANNER
Skyscanner is a leading global travel app that helps travellers plan and book their trip with ease and confidence. Every month, Skyscanner connects millions of travellers, in 52 countries and 37 languages, to more than 1200 trusted travel partners so they can find the best flight, hotel or car hire options.
Pricing and survey insights and methodology available on request.
SOURCE Skyscanner
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
an hour ago
- Associated Press
Battery X Metals Validates Provisional Patent Applications Filed with the United States Patent and Trademark Office Through Successful Real-World Trials of Next-Generation Lithium-Ion Battery Rebalancing Machine
News Release Highlights: VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / June 13, 2025 / Battery X Metals Inc. (CSE:BATX)(OTCQB:BATXF)(FSE:5YW, WKN:A40X9W) ('Battery X Metals' or the 'Company') an energy transition resource exploration and technology company, announces that further to its news release dated April 11, 2025-wherein the Company announced that its wholly-owned subsidiary, Battery X Rebalancing Technologies Inc. ('Battery X Rebalancing Technologies') submitted provisional patent applications (the 'Patent Applications') with the United States Patent and Trademark Office ('USPTO') for its next-generation battery rebalancing hardware and software platform-Battery X Rebalancing Technologies has now successfully validated the core innovations described in the filings through multiple real-world preliminary trials (the 'Preliminary Trials'). In a Preliminary Trial disclosed in the Company's news release dated May 30, 2025, Battery X Rebalancing Technologies tested its second-generation, patent-pending rebalancing machine ('Prototype 2.0") on a 96-cell Nissan Leaf battery pack (the 'Nissan Battery Pack'), representative of the second most common out-of-warranty electric vehicle model in the United States. The Nissan Battery Pack exhibited minor voltage imbalances typical of real-world use. Prototype 2.0 successfully rebalanced all 96 cells to 4.20 volts - the commonly recognized full charge state in the industry1 - achieving 100% recovery of imbalance-related capacity and restoring 1.95 ampere-hours, representing a 3.9% increase in usable capacity. The trial demonstrated the precision of Prototype 2.0 in restoring performance even on a relatively well-balanced battery pack, and supported its scalability across high-volume electric vehicle (EV) battery platforms. In a subsequent Preliminary Trial, as disclosed in the Company's news release dated June 6, 2025, Prototype 2.0 was tested on a significantly imbalanced 144-cell battery pack from a fully electric Class 3 commercial vehicle (the 'Electric Truck'). The Preliminary Trial was conducted on a battery pack exhibiting significant real-world imbalance and resulted in the recovery of 66.3 ampere-hours, representing a 37.7% recovery of the Rated Capacity, and 100% recovery of imbalance-induced capacity loss. The Electric Truck Preliminary Trial demonstrated the robustness of the technology under more demanding conditions and expanded Prototype 2.0's proven applicability to commercial vehicle platforms. 'The trials are confirming exactly what we filed with the USPTO,' said Massimo Bellini Bressi, CEO of Battery X Metals. 'To see both passenger and commercial electric vehicle battery platforms respond with full imbalance-related capacity recovery proves our technological innovations work-and it works where it matters most: in real-world environments with real-world degradation caused by battery cell imbalance.' Prototype 2.0 Together, these initiatives underscore Battery X Rebalancing Technologies' commitment to demonstrating the adaptability, precision, and commercial readiness of its rebalancing platform across a wide range of EV battery platforms. By validating performance on both passenger and commercial electric vehicles - with varying chemistries, architectures, and states of degradation - Battery X Rebalancing Technologies is building the foundation for broad-based adoption. These efforts reinforce its mission to deliver a scalable, software- and hardware-enabled solution capable of correcting imbalance-related degradation that affects millions of lithium-ion battery packs worldwide. Importantly, the Preliminary Trial results not only validate the technical functionality of Prototype 2.0, but also demonstrate its ability to recover substantial usable capacity otherwise lost to cell-level imbalance. This has clear implications for extending driving range, improving battery health, and reducing lifecycle costs for electric vehicle owners. The significance is amplified in the case of the Electric Truck, where nearly 40% of the pack's Rated Capacity was recovered, reinforcing Prototype 2.0's relevance in fleet and commercial contexts where battery degradation can severely impact performance, uptime, and asset value. The results support a broader opportunity to position Battery X Rebalancing Technologies as a first mover in battery lifespan extension and reconditioning, targeting the rapidly growing segment of electric vehicles anticipated to fall outside of their manufacturer's warranty, which is estimated to be nearly 40 million vehicles worldwide by 20312,3. Looking ahead, Battery X Rebalancing Technologies plans to continue its validation phase, which includes additional testing on a range of electric vehicle battery platforms and high-volume vehicle models. These efforts are designed to support the Company's progression from provisional to full utility patent applications, while also verifying system compatibility across multiple lithium-ion chemistries and configurations. This ongoing validation will play a critical role in expanding market readiness and demonstrating the commercial potential of Prototype 2.0 across both private and fleet-based EV markets. This milestone strengthens Battery X Rebalancing Technologies' strategic position as a first mover in the emerging EV battery rebalancing market, with a focus on extending battery life, reducing waste, and improving performance for electric vehicle owners and fleet operators. As EV adoption accelerates and more battery packs reach the end of their warranty period, the Company believes its technology offers a timely and scalable solution to a global challenge. Technologies Aimed to Advance the Energy Transition Battery X Rebalancing Technologies is a development-stage technology company, at the forefront of the energy transition, supporting the EV revolution and developing innovative technologies to extend the lifespan of lithium-ion and EV batteries. Its mission is to extend lithium-ion and EV battery longevity. The Patent Applications represent the culmination of multiple years of development, validation, and innovation by Battery X Rebalancing Technologies and mark a significant milestone toward solidifying its position in the lithium-ion and EV battery rebalancing and lifespan extension market. The company's next-generation rebalancing technology - validated by the National Research Council of Canada ('NRC'), as further described below-reinforces its commitment to delivering real-world solutions that support battery longevity and sustainability. The Problem: Rising EV Adoption Presents New Battery Lifecycle Challenges In 2024, global EV sales reached approximately 17.1 million units, representing a 25% increase from 20234. With cumulative global EV sales from 2015 to 2023 totaling an estimated over 40 million units5, a significant share of the global EV fleet is expected to exit warranty coverage over the coming years. By 2031, nearly 40 million electric, plug-in hybrid, and hybrid vehicles worldwide are anticipated to fall outside of their original warranty coverage6,7. This projection is based on current EV adoption figures and standard industry warranty terms, and underscores a growing risk for EV owners facing battery degradation, reduced capacity, and costly replacement requirements8. As the global EV fleet continues to expand, the demand for technologies that extend battery life, reduce long-term ownership costs, and support a sustainable transition to electric mobility is increasing. The Solution: Pioneering Next-Generation Technologies to Support Lithium-Ion Battery Longevity Battery X Rebalancing Technologies' proprietary software and hardware technology aims to address this challenge by extending the lifespan of EV batteries. This innovation is being developed with the aim to enhance the sustainability of electric transportation and the goal to provide EV owners with a more cost-effective, environmentally friendly ownership experience by reducing the need for costly battery replacements. Battery X Rebalancing Technologies' rebalancing technology, validated by the NRC, focuses on battery cell rebalancing. The NRC validation demonstrated the technology's ability to effectively correct cell imbalances in lithium-ion battery packs, recovering nearly all lost capacity due to cell imbalance. The validation was conducted on battery modules composed of fifteen 72Ah LiFePO₄ cells connected in series. The cells were initially balanced to a uniform state of charge (SOC), with a measured discharge capacity of 71.10Ah. In the validation test, three of the fifteen cells were then artificially imbalanced - one cell was charged to a 20% higher SOC, and two cells were discharged to a 20% lower SOC - resulting in a reduced discharge capacity of 46.24Ah, following rebalancing using Battery X Rebalancing Technologies' rebalancing technology. These advancements establish Battery X Rebalancing Technologies as a participant in lithium-ion and EV battery solutions, aiming to tackle the critical challenges of capacity degradation of battery packs and expensive replacements. By extending the lifecycle of battery materials within the supply chain, Battery X Rebalancing Technologies aims to support the energy transition and promote a more sustainable future. As disclosed in the Company's news release dated May 2, 2025, Battery X Rebalancing Technologies completed Prototype 2.0, the second-generation version of its patent-pending lithium-ion battery rebalancing machine. This advanced prototype incorporates significant refinements and updates over the original, including modified dimensions, optimized weight, and a full suite of accompanying equipment. Designed to reflect real-world use and commercial deployment readiness, Prototype 2.0 includes the core rebalancing system as well as a multi-function battery diagnostic device, system interface tablets, a battery pack lift, and insulated tool kits to support safe and effective field operations. Prototype 2.0 represents the culmination of several years of focused research and development and is engineered to integrate advanced hardware and software capabilities that identify battery degradation and optimize the performance of lithium-ion and EV batteries. The system includes advanced State-of-Health diagnostic modules that assess the maximum available capacity of EV battery cells, supporting both repair and second-life repurposing. Its next-generation rebalancing technology is designed to recover balance between individual cells, thereby extending operational life and optimizing energy output across the entire battery pack. In addition to technical performance, Prototype 2.0 features a more compact and efficient design footprint, and improved field usability. Expanded technical capabilities include deciphering tools, airtightness testing modules, and new connectivity ports, all of which position the system for future commercial deployment. Prototype 2.0 marks a major milestone in establishing Battery X Rebalancing Technologies as a participant in EV battery lifespan extension and rebalancing solutions. The Company encourages all shareholders, stakeholders, industry participants, and interested parties to watch the featured videos herein to gain a deeper understanding of Prototype 2.0's patent-pending technology, the rebalancing process, and the significance of successfully validating the core innovations described in the Patent Applications through multiple real-world Preliminary Trials. Watch the featured videos here: Patent Applications Battery X Rebalancing Technologies' first patent application, method and system for battery pack adjustment, introduces a novel solution to address the common issue of imbalanced battery cells within a battery pack - an issue that leads to reduced capacity, safety concerns, and shortened lifespan. In most battery packs, cells charge and discharge at different rates due to variations in manufacturing, internal resistance, and temperature, which causes some cells to reach full charge or depletion before others. As a result, traditional battery management systems (BMS) cut off charging or discharging based on the weakest cell, wasting the remaining potential of other cells. This invention solves that problem through a smart system that continuously monitors and adjusts the state of charge (SOC) of each group of cells (referred to as 'strings'). The system includes a display controller (which manages operations), a charger and discharger (handling overall energy flow), and an equalizer (which precisely adjusts each string). By allocating charge and discharge intelligently across the cells, the system ensures they all reach full capacity and deplete evenly, thereby maximizing usable energy, detecting early signs of degradation, enhancing safety, and extending the overall life of the battery pack. The second patent application, for two-wire charging and remote voltage detection, presents a streamlined method to charge a battery and measure its voltage using only two wires-significantly reducing system complexity and hardware costs. In conventional battery systems, separate wires or sensors are typically required to monitor voltage during charging, which adds material costs and design challenges, especially in large-scale applications like electric vehicles or grid storage. This invention enables both functions over the same wire pair by briefly pausing the charge current, opening a switch, and using that moment to measure the battery's voltage through the same lines. A pulse isolation drive circuit is used to manage this operation safely and reliably, even when voltage levels are floating or unstable. The result is a simplified yet highly accurate system that maintains the integrity of voltage readings while eliminating the need for redundant hardware. This two-wire approach offers a more efficient and cost-effective solution for modern battery systems that demand reliability, safety, and scalability. 1 Battery University, 2, IEA, 3 U.S. News 4 Rho Motion - Global EV Sales 2024, 5 IEA Global EV Outlook 2024, 6 IEA, 7 U.S. News, 8 Recurrent Auto About Battery X Metals Inc. Battery X Metals (CSE:BATX) (OTCQB:BATXF) (FSE:5YW, WKN:A40X9W) is an energy transition resource exploration and technology company committed to advancing domestic and critical battery metal resource exploration and developing next-generation proprietary technologies. Taking a diversified, 360° approach to the battery metals industry, the Company focuses on exploration, lifespan extension, and recycling of lithium-ion batteries and battery materials. For more information, visit On Behalf of the Board of Directors Massimo Bellini Bressi, Director For further information, please contact: Massimo Bellini Bressi Chief Executive Officer Email: [email protected] Tel: (604) 741-0444 Disclaimer for Forward-Looking Information This news release contains forward-looking statements within the meaning of applicable securities laws. Forward-looking statements in this release relate to, among other things, the Company's objectives, strategies, and future plans regarding the continued development, validation, patenting, and commercialization of proprietary lithium-ion battery rebalancing software and hardware technologies. Specific forward-looking statements include, but are not limited to, statements regarding the performance, applicability, and scalability of Prototype 2.0 across electric vehicle battery platforms; the Company's ability to file and obtain full utility patents from the USPTO; the anticipated benefits of the Company's rebalancing technology in extending battery life, restoring lost capacity, and reducing the need for costly replacements; the Company's positioning as a participant in the EV battery rebalancing and lifespan extension market; and the potential market adoption and commercial deployment of the Company's proprietary platform. These forward-looking statements are based on current expectations, estimates, assumptions, and projections that the Company believes to be reasonable as of the date of this release. However, such statements are inherently subject to significant technological, scientific, business, operational, regulatory, and economic risks and uncertainties. Actual results, performance, or achievements may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to: uncertainties related to the USPTO patent application process and the scope of intellectual property protection ultimately granted; challenges in achieving consistent results across different battery chemistries, configurations, and EV platforms; delays in further testing, development, or market readiness of Prototype 2.0; risks related to commercial deployment and market acceptance; changes in industry demand, regulation, or competitive landscape; and general macroeconomic, geopolitical, and capital market conditions. Forward-looking statements reflect the beliefs, assumptions, and expectations of management at the time they are made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable law. Readers are cautioned not to place undue reliance on forward-looking statements and are encouraged to consult the Company's continuous disclosure filings available under its profile at for additional risk factors and further information. SOURCE: Battery X Metals press release
Associated Press
an hour ago
- Associated Press
Medical Chronology Outsourcing Improves with Stronger Client Communication, Expert Says
06/13/2025, New York // KISS PR Brand Story PressWire // As demand rises for fast and accurate medical chronologies in legal and insurance cases, experts are pointing to one key factor that makes outsourcing success: communication. Medical chronology outsourcing work has become a common solution for law firms, insurance companies, and Medical Examiners dealing with overwhelming volumes of medical records. But industry professionals say the quality of communication between clients and vendors directly influences outcomes impacting everything from accuracy to turnaround times. Collaboration Over Transaction 'Outsourcing doesn't work if it's treated like a hand-off,' says a legal nurse consultant in Chicago. 'It needs to be collaborative. You need two-way communication, regular updates, and shared understanding of what the case requires.' Service providers echo this sentiment. Many outsourcing teams now prioritize setting up detailed onboarding calls, using checklists to gather case-specific preferences, and scheduling progress reviews throughout the project. Reducing Errors and Delays Miscommunication or lack of communication can lead to costly mistakes. These may include missed injuries, incorrect timelines, or overlooked documents. Even minor errors in a medical chronology can delay litigation or settlements. 'Clear instructions and quick clarifications from clients help us work faster and more precisely,' said an operations director at a major medical chronology service provider. 'When we have questions, timely responses avoid delays and reduce the need for revisions.' Building Trust with Transparency Security and transparency are also communication-driven. Clients want to know how records are handled, how data is protected, and what steps are taken at each stage of the process. Frequent, open communication builds trust and ensures compliance with strict privacy regulations like HIPAA. LezDo TechMed, a leading provider of medical chronology services, is streamlining case preparation for personal injury attorneys, insurance companies, and medical experts. Known for its collaborative approach, the company emphasizes clear communication and consistently delivers detailed, high-quality medical chronologies tailored to legal needs. The Competitive Advantage In a competitive field where turnaround time and accuracy can define success, firms that invest in structured communication with their outsourcing partners are seeing better results. As outsourcing continues to grow across the legal-medical field, industry experts agree: communication isn't just helpful but it's essential. Those who communicate clearly, frequently, and securely will be the ones who lead the future of medical chronology services. Media Details: Contact Person: Robert Smith Organisation: LezDo TechMed Email: [email protected] Country: USA
Associated Press
an hour ago
- Associated Press
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
New York, New York--(Newsfile Corp. - June 13, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between February 27, 2025 and May 26, 2025, both dates inclusive (the 'Class Period'). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 11, 2025. SO WHAT: If you purchased Rocket Pharmaceuticals securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Rocket Pharmaceuticals class action, go to or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 11, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of RP-A501's safety and clinical trial protocol; notably, that Rocket Pharmaceuticals knew Serious Adverse Events (SAEs), including death of participants enrolled in the study, were a risk. In particular, Rocket Pharmaceuticals amended the trial's protocol to introduce a novel immunomodulatory agent to the pretreatment regimen without providing this critical update to shareholders. Such statements absent these material facts caused shareholders to purchase Rocket Pharmaceuticals securities at artificially inflated prices. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Rocket Pharmaceuticals class action, go to or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] To view the source version of this press release, please visit
